Home/Filings/4/0001140361-24-043695
4//SEC Filing

GILMAN STEVEN C 4

Accession 0001140361-24-043695

CIK 0000887359other

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 4:05 PM ET

Size

8.1 KB

Accession

0001140361-24-043695

Insider Transaction Report

Form 4
Period: 2024-10-16
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-16+5,8330 total
    Exercise: $13.05Exp: 2028-05-02Common Stock (5,833 underlying)
  • Exercise/Conversion

    Common Stock

    2024-10-16$13.05/sh+5,833$76,12116,833 total
  • Sale

    Common Stock

    2024-10-16$41.36/sh5,833$241,25311,000 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
  • [F2]These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001379970

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:05 PM ET
Size
8.1 KB